Quantinuum Stock Rises 13% to $77.15
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 day ago
0mins
Quantinuum is up 13.0%, or $8.88 to $77.15.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy QNT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on QNT
Wall Street analysts forecast QNT stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 77.460
Low
Averages
High
Current: 77.460
Low
Averages
High
No data
About QNT
Quantinuum Inc. is a provider of quantum computing platform, which offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property. The Company's vertically integrated quantum computing platform combines quantum hardware systems and middleware with application software designed to make quantum computing deployable in real-world environments built on the Quantum Charge‑Coupled Device architecture. Its products and solutions include Quantinuum Systems, Helios, Quantum Origin, InQuanto and Nexus. Nexus is a quantum computing platform for accessing and managing performance full stack. InQuanto is a quantum computational chemistry for complex molecular and materials simulations. Quantum Origin is a quantum random number generator designed for encryption and protect data. Its developer tools include TKET, Guppy and Lambeq. It operates across pharmaceuticals, materials science, financial services, government and industrial markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Microsoft's Quantum Computing Breakthrough Faces Scrutiny
- Journal Critique: A critique in Nature by Henry Legg raises concerns about Microsoft's claimed quantum computing breakthrough, highlighting inconsistencies and misreported outcomes in a key paper, which could jeopardize Microsoft's future quantum initiatives.
- Quantum Computing Goals: Microsoft aims to achieve a working quantum system by 2029; however, Legg's criticisms may undermine investor confidence in its technological progress, especially when compared to rivals like IBM and Google.
- Unpublished Major Discovery: Microsoft claimed last year to have discovered the Majorana particle related to quantum computing, yet it has not published this finding in a peer-reviewed journal, potentially questioning the credibility of its research and affecting its leadership in the quantum computing space.
- Rival Advantages: Unlike Microsoft, competitors such as IBM and Quantinuum have developed quantum computing methods that are more widely supported and validated, posing greater challenges for Microsoft and potentially impacting its market share.
See More
SpaceX's Historic IPO Drives Record 2Q Market Recovery
- Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies going public and raising a record $104.9 billion, indicating a resurgence of market confidence.
- SpaceX's Major Deal: SpaceX raised $75 billion in its IPO, surpassing the total of all US IPOs from the previous two years combined, achieving a market cap of $1.7 trillion at listing, making it one of the largest public companies on US exchanges.
- Strong First Day Performance: SpaceX's stock rose 19% on its debut, alleviating concerns about an overly hot or cold opening, although aftermarket trading remained volatile.
- Large Deal Momentum: Even without SpaceX's deal, Q2 would have been the largest quarter for IPO proceeds since 2021, with nine other IPOs raising over $1 billion, showcasing the ongoing appeal of large transactions.
See More
Boundless Bio Merges with Serapha Bio, Stocks Surge
- Boundless Bio Merger: Boundless Bio shares reached a 52-week high of $2.75 after agreeing to merge with private biotech firm Serapha Bio in an all-stock deal, focusing on developing clinical-stage gene-editing treatments for severe Alpha-1 Antitrypsin Deficiency.
- Funding Support: The merger includes $230 million in funding from healthcare investors, which is expected to provide essential capital for Boundless Bio's drug development and clinical trials, thereby strengthening its market position in the gene-editing space.
- Backblaze Major Agreement: Backblaze shares climbed to a two-year high of $11.85 after announcing a five-year, approximately $335 million deal with AI cloud provider CoreWeave, positioning Backblaze as a key storage provider for large-scale AI workloads.
- Market Sentiment Shift: As Boundless Bio and Backblaze stocks surged, investor sentiment significantly improved, with Boundless Bio's sentiment shifting from neutral to 'extremely bullish' and Backblaze's sentiment moving from bearish to 'extremely bullish'.
See More
Quantum Stocks Surge 15% Following Trump's Executive Orders
- Quantum Stock Rally: Following President Trump's signing of two executive orders aimed at quantum technology, Quantinuum (QNT) shares surged 15% during Tuesday morning trading, indicating a significant boost in market confidence towards emerging tech stocks.
- Strong IPO Performance: Quantinuum, which went public earlier this month, has seen its stock price rise well above its IPO price of $60, reflecting strong investor expectations for future growth and providing a positive signal for other newly listed quantum companies like Infleqtion (INFQ).
- Increased Government Support: Trump's first executive order aims to advance the development of a national quantum computer, directing federal agencies to create deployment plans for quantum-enabled sensors and networks within the next five years, which will bring more funding and policy support to the quantum tech sector.
- Transition to New Encryption Standards: The second executive order mandates federal agencies to transition high-value assets to encryption standards resistant to quantum attacks by 2031, accelerating the adoption of post-quantum cryptography and further promoting the application of quantum technology in cybersecurity.
See More
Analysis of Rigetti Computing's Stock Volatility
- Stock Pullback: Rigetti Computing's stock has fallen from an all-time high of $58 in October to around $21 currently, indicating a potential waning of market enthusiasm for quantum computing, prompting investors to carefully assess buying opportunities.
- Government Funding Support: The U.S. government announced it would provide Rigetti with up to $100 million in funding, which, despite potential strings attached, serves as a positive signal for the quantum computing industry and strengthens Rigetti's market position.
- Financial Performance: In Q1 2026, Rigetti's revenue tripled year-over-year to $4.4 million, although operating losses increased; however, the company maintains over $400 million in cash, ensuring its ability to continue development.
- Intense Market Competition: The quantum computing sector is highly competitive, with Rigetti facing challenges from companies like IonQ and D-Wave, as well as tech giants like Google and IBM; nevertheless, government backing and ample cash flow position it for future potential.
See More
U.S. Government to Invest $100 Million in Rigetti
- Government Backing: The U.S. government has signed a letter of intent to invest $100 million in Rigetti over the next three years, which is a positive development for the quantum computing industry, although it may come with several strings attached.
- Revenue Growth Potential: Rigetti's revenue tripled year-over-year in Q1 2026 to $4.4 million, driven by research deals and sales of experimental systems, despite significant operating losses still being a concern.
- Liquidity Advantage: The company boasts over $400 million in cash and equivalents on its balance sheet, providing a solid runway for continued development while seeking commercial applicability, indicating strong financial health.
- Intense Market Competition: Although Rigetti's stock has fallen over 4% in 2026, it has still risen nearly 85% over the past 12 months, facing competition from players like IonQ and D-Wave, with its long-term success hinging on the realization of commercial applications.
See More
Microsoft's Quantum Computing Breakthrough Faces Scrutiny
- Journal Critique: A critique in Nature by Henry Legg raises concerns about Microsoft's claimed quantum computing breakthrough, highlighting inconsistencies and misreported outcomes in a key paper, which could jeopardize Microsoft's future quantum initiatives.
- Quantum Computing Goals: Microsoft aims to achieve a working quantum system by 2029; however, Legg's criticisms may undermine investor confidence in its technological progress, especially when compared to rivals like IBM and Google.
- Unpublished Major Discovery: Microsoft claimed last year to have discovered the Majorana particle related to quantum computing, yet it has not published this finding in a peer-reviewed journal, potentially questioning the credibility of its research and affecting its leadership in the quantum computing space.
- Rival Advantages: Unlike Microsoft, competitors such as IBM and Quantinuum have developed quantum computing methods that are more widely supported and validated, posing greater challenges for Microsoft and potentially impacting its market share.
See More
SpaceX's Historic IPO Drives Record 2Q Market Recovery
- Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies going public and raising a record $104.9 billion, indicating a resurgence of market confidence.
- SpaceX's Major Deal: SpaceX raised $75 billion in its IPO, surpassing the total of all US IPOs from the previous two years combined, achieving a market cap of $1.7 trillion at listing, making it one of the largest public companies on US exchanges.
- Strong First Day Performance: SpaceX's stock rose 19% on its debut, alleviating concerns about an overly hot or cold opening, although aftermarket trading remained volatile.
- Large Deal Momentum: Even without SpaceX's deal, Q2 would have been the largest quarter for IPO proceeds since 2021, with nine other IPOs raising over $1 billion, showcasing the ongoing appeal of large transactions.
See More
Boundless Bio Merges with Serapha Bio, Stocks Surge
- Boundless Bio Merger: Boundless Bio shares reached a 52-week high of $2.75 after agreeing to merge with private biotech firm Serapha Bio in an all-stock deal, focusing on developing clinical-stage gene-editing treatments for severe Alpha-1 Antitrypsin Deficiency.
- Funding Support: The merger includes $230 million in funding from healthcare investors, which is expected to provide essential capital for Boundless Bio's drug development and clinical trials, thereby strengthening its market position in the gene-editing space.
- Backblaze Major Agreement: Backblaze shares climbed to a two-year high of $11.85 after announcing a five-year, approximately $335 million deal with AI cloud provider CoreWeave, positioning Backblaze as a key storage provider for large-scale AI workloads.
- Market Sentiment Shift: As Boundless Bio and Backblaze stocks surged, investor sentiment significantly improved, with Boundless Bio's sentiment shifting from neutral to 'extremely bullish' and Backblaze's sentiment moving from bearish to 'extremely bullish'.
See More
Quantum Stocks Surge 15% Following Trump's Executive Orders
- Quantum Stock Rally: Following President Trump's signing of two executive orders aimed at quantum technology, Quantinuum (QNT) shares surged 15% during Tuesday morning trading, indicating a significant boost in market confidence towards emerging tech stocks.
- Strong IPO Performance: Quantinuum, which went public earlier this month, has seen its stock price rise well above its IPO price of $60, reflecting strong investor expectations for future growth and providing a positive signal for other newly listed quantum companies like Infleqtion (INFQ).
- Increased Government Support: Trump's first executive order aims to advance the development of a national quantum computer, directing federal agencies to create deployment plans for quantum-enabled sensors and networks within the next five years, which will bring more funding and policy support to the quantum tech sector.
- Transition to New Encryption Standards: The second executive order mandates federal agencies to transition high-value assets to encryption standards resistant to quantum attacks by 2031, accelerating the adoption of post-quantum cryptography and further promoting the application of quantum technology in cybersecurity.
See More
Analysis of Rigetti Computing's Stock Volatility
- Stock Pullback: Rigetti Computing's stock has fallen from an all-time high of $58 in October to around $21 currently, indicating a potential waning of market enthusiasm for quantum computing, prompting investors to carefully assess buying opportunities.
- Government Funding Support: The U.S. government announced it would provide Rigetti with up to $100 million in funding, which, despite potential strings attached, serves as a positive signal for the quantum computing industry and strengthens Rigetti's market position.
- Financial Performance: In Q1 2026, Rigetti's revenue tripled year-over-year to $4.4 million, although operating losses increased; however, the company maintains over $400 million in cash, ensuring its ability to continue development.
- Intense Market Competition: The quantum computing sector is highly competitive, with Rigetti facing challenges from companies like IonQ and D-Wave, as well as tech giants like Google and IBM; nevertheless, government backing and ample cash flow position it for future potential.
See More
U.S. Government to Invest $100 Million in Rigetti
- Government Backing: The U.S. government has signed a letter of intent to invest $100 million in Rigetti over the next three years, which is a positive development for the quantum computing industry, although it may come with several strings attached.
- Revenue Growth Potential: Rigetti's revenue tripled year-over-year in Q1 2026 to $4.4 million, driven by research deals and sales of experimental systems, despite significant operating losses still being a concern.
- Liquidity Advantage: The company boasts over $400 million in cash and equivalents on its balance sheet, providing a solid runway for continued development while seeking commercial applicability, indicating strong financial health.
- Intense Market Competition: Although Rigetti's stock has fallen over 4% in 2026, it has still risen nearly 85% over the past 12 months, facing competition from players like IonQ and D-Wave, with its long-term success hinging on the realization of commercial applications.
See More
